Page last updated: 2024-08-25

methotrexate and Acidosis, Renal Tubular, Type I

methotrexate has been researched along with Acidosis, Renal Tubular, Type I in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bhandari, S; Jain, G; Kalra, S; Vasnik, G1
Rosen, G1

Reviews

1 review(s) available for methotrexate and Acidosis, Renal Tubular, Type I

ArticleYear
An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Acidosis, Renal Tubular; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Osteosarcoma; Postoperative Care; Preoperative Care; Radionuclide Imaging; Retrospective Studies; Salvage Therapy; Thallium Radioisotopes; Treatment Outcome

1993

Other Studies

1 other study(ies) available for methotrexate and Acidosis, Renal Tubular, Type I

ArticleYear
Primary Sjogren's syndrome manifesting with distal renal tubular acidosis and severe metabolic bone disease.
    BMJ case reports, 2020, Jun-01, Volume: 13, Issue:6

    Topics: Absorptiometry, Photon; Acidosis, Renal Tubular; Adolescent; Antirheumatic Agents; Arthralgia; Bone and Bones; Bone Diseases, Metabolic; Female; Humans; Hydroxychloroquine; Hypokalemia; Immunologic Tests; Methotrexate; Mobility Limitation; Prednisolone; Sjogren's Syndrome; Treatment Outcome; Urinalysis

2020